Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the c...

by Waaga-Gasser Ana, Tsaur Igor, Juengel Eva, Makarević Jasmina, Seibel Jens-Michael, Hudak Lukasz, Wedel Steffen, Haferkamp Axel, Blaheta Roman A
Published 2011-08-01

Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma

by Pfitzenmaier Jesco, Schirmacher Peter, Hoppe-Seyler Karin, Hüsing Johannes, Pritsch Maria, Macher-Goeppinger Stephan, Wagener Nina, Haferkamp Axel, Hoppe-Seyler Felix, Hohenfellner Markus
Published 2010-10-01

Renal tumors and second primary pancreatic tumors: a relationship with clinical impact?

by Müller Sascha A, Pahernik Sascha, Hinz Ulf, Martin David J, Wente Moritz N, Hackert Thilo, Leowardi Christine, Haferkamp Axel, Büchler Markus W, Schmied Bruno M
Published 2012-08-01